Zenith Healthcare Limited

As of June 30, 2026, Zenith Healthcare Limited carries a market capitalization of 164.98M, placing it among publicly traded companies globally. Its enterprise value stands at 164.98M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Zenith Healthcare Limited has 53.74M shares outstanding.

As of June 30, 2026, Zenith Healthcare Limited trades at a trailing price-to-earnings ratio of 104.72.

As of June 30, 2026, Zenith Healthcare Limited trades at an EV/EBITDA multiple of 96.09 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.53 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 164.98M versus a market cap of 164.98M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 2.48M in revenue per employee across its workforce of 43.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Zenith Healthcare Limited recorded 633,000.00 in income tax expense. That works out to an effective tax rate of 28.35, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.23M, leaving 1.60M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Zenith Healthcare Limited's stock has declined approximately 21.27% over the past 52 weeks. The 50-day moving average sits at 3.16, while the 200-day moving average is 3.21.

Over the twelve months ended June 30, 2026, Zenith Healthcare Limited generated 108.04M in revenue and converted that into 1.60M in net income, yielding earnings per share of 0.03. EBITDA reached 1.72M, while operating income came in at -874,000.00.

Over the twelve months ended June 30, 2026, Zenith Healthcare Limited posted a gross margin of 55.35, reflecting its pricing power and cost economics. The operating margin of -0.81 and net profit margin of 1.48 provide insight into operational efficiency.

Zenith Healthcare Limited's most recent stock split took place on October 28, 2005 with a 1:10 split ratio.